Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTNNB1 | P35222 | 1/20 | 0.60 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | PARP1 | P09874 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29425468 | 0.83 | CTNNB1 (0.60) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL7693879 | 0.82 | CTNNB1 (0.77) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL7751522 | 0.82 | CTNNB1 (0.70) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL1456962 | 0.80 | CTNNB1 (0.62) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL5427931 | 0.80 | KDM4E (0.59) | KDM4EMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL27379724 | 0.80 | CTNNB1 (0.62) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL264288 | 0.78 | IRAK4 (0.63) | CTNNB1IRAK4MAPTALDH1A1MEN1 | |
| SCHEMBL11852729 | 0.78 | CTNNB1 (0.60) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL9457629 | 0.78 | CTNNB1 (0.60) | CTNNB1IRAK4KDM4EMAPTALDH1A1 | |
| SCHEMBL7671145 | 0.78 | CTNNB1 (0.60) | CTNNB1IRAK4KDM4EMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1193904-A | Personal cleansing kit comprising polymeric diamond-mesh bath sponge and cleaning solution containing halogenated biocide | UNILEVER PLC (NL) | 1998-09-23 | — | — | CN | claimed |
| US-20240327442-A1 | CONTROLLING METAL-ORGANIC FRAMEWORK MORPHOLOGY THROUGH COORDINATIVE MIMICRY | ExxonMobil Technology and Engineering Company | 2024-10-03 | — | — | US | disclosed |
| EP-4380944-A1 | CONTROLLING METAL-ORGANIC FRAMEWORK MORPHOLOGY THROUGH COORDINATIVE MIMICRY | The Regents of the University of California (US) | 2024-06-12 | — | — | EP | disclosed |
| CN-118076618-A | Control of metal-organic framework morphology by coordination modeling | 加利福尼亚大学董事会 | 2024-05-24 | — | — | CN | disclosed |
| WO-2023014513-A1 | CONTROLLING METAL-ORGANIC FRAMEWORK MORPHOLOGY THROUGH COORDINATIVE MIMICRY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-02-09 | — | — | WO | disclosed |
| US-20110269763-A1 | CRTH2 receptor ligands for medicinal uses | 7TM PHARMA A/S (DK) | 2011-11-03 | — | — | US | disclosed |
| US-8022063-B2 | CRTH2 receptor ligands for medicinal uses | 7TM PHARMA A/S (DK) | 2011-09-20 | — | — | US | disclosed |
| EP-2336113-A1 | CRTH2 Receptor Ligands for Medical Use | 7TM Pharma A/S (DK) | 2011-06-22 | — | — | EP | disclosed |
| US-20090099189-A1 | CRTH2 Receptor Ligands For Medicinal Uses | 7TM PHARMA A/S (DK) | 2009-04-16 | — | — | US | disclosed |
| EP-1758579-A1 | CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES | 7TM Pharma A/S (DK) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005115382-A1 | CRTH2 RECEPTOR LIGANDS FOR MEDICINAL USES | 7TM PHARMA A/S (DK) | 2005-12-08 | — | — | WO | disclosed |
| CN-1688549-A | Compound having TGF-beta inhibitory activity and medicinal composition containing the same | KIRIN BREWERY (JP) | 2005-10-26 | — | — | CN | disclosed |
| CN-1222270-C | Oral compositions | SUNSTAR INC (JP) | 2005-10-12 | — | — | CN | disclosed |
| CN-1204506-A | Oral compositions | SUNSTAR INC (JP) | 1999-01-13 | — | — | CN | disclosed |
| CN-1193904-A | Personal cleansing kit comprising polymeric diamond-mesh bath sponge and cleaning solution containing halogenated biocide | UNILEVER PLC (NL) | 1998-09-23 | — | — | CN | disclosed |
| CN-1064013-A | The human body foam abluent that contains the foam enhancing polymer | PROCTER & GAMBLE (US) | 1992-09-02 | — | — | CN | disclosed |
| CN-1055109-A | Cleaning product | PROCTER & GAMBLE (US) | 1991-10-09 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327442-A1 | CONTROLLING METAL-ORGANIC FRAMEWORK MORPHOLOGY THROUGH COORDINATIVE MIMICRY | TPR, CA4, CA2 | CTNNB1 2968/4885IRAK4 1216/4885KDM4E 868/4885 |
| US-20090099189-A1 | CRTH2 Receptor Ligands For Medicinal Uses | HRH1, HRH2, HRH3 | CTNNB1 1396/4885IRAK4 2207/4885KDM4E 4637/4885 |
| US-20110269763-A1 | CRTH2 receptor ligands for medicinal uses | HRH1, HRH2, HRH4 | CTNNB1 1020/4885IRAK4 1860/4885KDM4E 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.